학술논문
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial
Document Type
Article
Author
Source
In: International Journal of Molecular Sciences . (International Journal of Molecular Sciences, January 2023, 24(1))
Subject
Language
English
ISSN
14220067
16616596
16616596